Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Boehringer Ingelheim
Moodys
Baxter
Harvard Business School

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

COLESTIPOL HYDROCHLORIDE - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for colestipol hydrochloride and what is the scope of patent protection?

Colestipol hydrochloride is the generic ingredient in three branded drugs marketed by Pharmacia Upjohn and Impax Labs, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for colestipol hydrochloride. Three suppliers are listed for this compound.

Recent Clinical Trials for COLESTIPOL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Laboratorios Grossman, S.A.Phase 3
Instituto Nacional de Salud Publica, MexicoPhase 3
University of South FloridaPhase 1

See all COLESTIPOL HYDROCHLORIDE clinical trials

Pharmacology for COLESTIPOL HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for COLESTIPOL HYDROCHLORIDE
Synonyms for COLESTIPOL HYDROCHLORIDE
37296-80-3
AC1MJ2ZS
C11H28ClN5O.HCl
C60H114O8.HCl
Colestid
Colestipol HCl
Colestipol hydrochloride [USAN:USP]
Colestipol hydrochloride [USAN]
Copolymer of diethylenetriamine and 1-chloro-2,3-epoxypropane, hydrochloride (with approximately 1 out of 5 amine nitrogens protonated)
DTXSID40190737
Flavored Colestid
FT-0749664
GACQNVJDWUAPFY-UHFFFAOYSA-N
Lestid
LS-54700
N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine hydrochloride
SCHEMBL284758
tetraethylenepentamine HCl
U-26597A
UNII-X7D10K905G
X7D10K905G

US Patents and Regulatory Information for COLESTIPOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-002 Approved Prior to Jan 1, 1982 RX Yes No   Start Trial   Start Trial   Start Trial
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-004 Sep 22, 1995 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Impax Labs COLESTIPOL HYDROCHLORIDE colestipol hydrochloride GRANULE;ORAL 077277-001 May 2, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-003 Sep 22, 1995 AB RX Yes No   Start Trial   Start Trial   Start Trial
Impax Labs COLESTIPOL HYDROCHLORIDE colestipol hydrochloride GRANULE;ORAL 077277-002 May 2, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for COLESTIPOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Pharmacia Upjohn COLESTID colestipol hydrochloride TABLET;ORAL 020222-001 Jul 19, 1994   Start Trial   Start Trial
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Express Scripts
Baxter
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.